Case report: Life-saving pulmonary endarterectomy for a young female with primary antiphospholipid syndrome complicated by severe chronic thromboembolic pulmonary hypertension

[1] Galiè N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37:67-119.10.1093/eurheartj/ehv317Search in Google Scholar

[2] Madani MM, Auger WR, Pretorius V, et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg 2012;94:97-103; discussion 103.10.1016/j.athoracsur.2012.04.004Search in Google Scholar

[3] Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost JTH 2006;4:295-306.10.1111/j.1538-7836.2006.01753.xSearch in Google Scholar

[4] Banks DA, Pretorius GVD, Kerr KM, Manecke GR. Pulmonary endarterectomy: part I. Pathophysiology, clinical manifestations, and diagnostic evaluation of chronic thromboembolic pulmonary hypertension. Semin Cardiothorac Vasc Anesth 2014;18:319-30.10.1177/1089253214536621Search in Google Scholar

[5] Mayer E, Klepetko W. Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:589-93.10.1513/pats.200605-120LRSearch in Google Scholar

[6] Lang IM, Pesavento R, Bonderman D, Yuan JX-J. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J 2013;41:462-8.10.1183/09031936.00049312Search in Google Scholar

[7] Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 2011;124:1973-81.10.1161/CIRCULATIONAHA.110.015008Search in Google Scholar

[8] Porres-Aguilar M, Pena-Ruiz MA, Burgos JD, Porres- Munoz M, Hughes HW. Chronic thromboembolic pulmonary hypertension as an uncommon presentation of primary antiphospholipid syndrome. J Natl Med Assoc 2008;100:734-6.10.1016/S0027-9684(15)31351-1Search in Google Scholar

[9] Romano AM, Tomaselli S, Gualtieri G, et al. Respiratory function in precapillary pulmonary hypertension. Monaldi Arch Chest Dis Arch Monaldi Mal Torace 1993;48:201-4.Search in Google Scholar

[10] Auger WR, Kerr KM, Kim NH, Fedullo PF. Evaluation of patients with chronic thromboembolic pulmonary hypertension for pulmonary endarterectomy. Pulm Circ 2012;2:155-62.10.4103/2045-8932.97594340186922837856Search in Google Scholar

[11] Pepke-Zaba J, Hoeper MM, Humbert M. Chronic thromboembolic pulmonary hypertension: advances from bench to patient management. Eur Respir J 2013;41:8-9.10.1183/09031936.0018121223277517Search in Google Scholar

[12] Thistlethwaite PA, Kaneko K, Madani MM, Jamieson SW. Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg Off J Assoc Thorac Cardiovasc Surg Asia 2008;14:274-82.Search in Google Scholar

[13] Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:637-48.10.1183/09031936.04.0007970415083767Search in Google Scholar

[14] Thistlethwaite PA, Kemp A, Du L, Madani MM, Jamieson SW. Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 2006;131:307-13.10.1016/j.jtcvs.2005.07.03316434258Search in Google Scholar

[15] Mayer E. Surgical treatment of chronic thromboembolic pulmonary hypertension. Swiss Med Wkly 2006;136:491-7.10.4414/smw.2006.11167Search in Google Scholar

[16] Camous J, Decrombecque T, Louvain-Quintard V, Doubine S, Dartevelle P, Stéphan F. Outcomes of patients with antiphospholipid syndrome after pulmonary endarterectomy. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg 2014;46:116-20.10.1093/ejcts/ezt57224362260Search in Google Scholar

[17] D’Armini AM, Totaro P, Nicolardi S, et al. Impact of high titre of antiphospholipid antibodies on postoperative outcome following pulmonary endarterectomy. Interact Cardiovasc Thorac Surg 2010;10:418-22.10.1510/icvts.2009.22163019934162Search in Google Scholar

[18] Comellas-Kirkerup L, Hernández-Molina G, Cabral AR. Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study. Blood 2010;116:3058-63.10.1182/blood-2010-05-28350720625007Search in Google Scholar

[19] Uthman I, Godeau B, Taher A, Khamashta M. The hematologic manifestations of the antiphospholipid syndrome. Blood Rev 2008;22:187-94.10.1016/j.blre.2008.03.00518417261Search in Google Scholar

[20] Ghofrani H-A, D’Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 2013;369:319-29.10.1056/NEJMoa120965723883377Search in Google Scholar